News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Hidehito Horinouchi: Honored to have been nominated for IASLC 2025 Board of Directors Election
Hidehito Horinouchi/X
Apr 20, 2025, 12:15

Hidehito Horinouchi: Honored to have been nominated for IASLC 2025 Board of Directors Election

Hidehito HORINOUCHI, Assistant Chief of the National Cancer Center Hospital, shared a post on X:

“I am humbly honored to have been nominated for IASLC 2025 Board of Directors Election 2025 .

Undesignated Seat #2 Vision for Global Education.

I would truly appreciate your valuable support.”

Hidehito Horinouchi: Honored to have been nominated for IASLC 2025 Board of Directors Election

Amy C. Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, reshared the post on X, adding:

“I am honored to support Hidehito HORINOUCHI for election to the IASLC Board of Directors.”

Amy C. Moore cancer fight against cancer Global fight against cancer Hidehito Horinouchi IASLC 2025 Board of Directors LUNGevity Foundation National Cancer Center Hospital OncoDaily Oncology
Special Coverage
Voices
Aug 21, 2025, 15:59
George Kumar: The interplay Between Cardiovascular Disease (CVD) and Cancer
Voices
Aug 21, 2025, 15:47
European Society of Gynaecological Oncology Announces that Applications are Open for Editor-in-Chief of IJGC
Insight
Aug 21, 2025, 15:37
Carolina Reduzzi: ctDNA Landscape Analysis Post CDK4/6 Inhibitor in HR+/HER2- Metastatic Breast Cancer
Voices
Aug 21, 2025, 15:30
Clinician-Scientists Awarded NMRC Transition Awards for Precision Lung Cancer Research - National Cancer Centre Singapore
Voices
Aug 21, 2025, 15:22
Construction of the $658 million Sydney Children’s Hospital Stage One and MCCCC Project Has Reached Completion
Oncolibrary
Aug 21, 2025, 15:00
Breakthrough Emactuzumab Phase 3 TANGENT Trial in TGCT: SynOx Pharma Reports Enrollment Completed Ahead of Schedule
Voices
Aug 21, 2025, 14:50
Andrea Apolo Highlights the Top 5 Clinical Advances in Bladder Cancer Treatment for 2024
Insight
Aug 21, 2025, 14:47
Loay Kassem: Study Reveals BRCA Mutation Rates in Egyptian Women with Breast or Ovarian Cancer
Insight
Aug 21, 2025, 14:41
Tiago Cordeiro Felismino: Exploring the Role of Neutrophil-to-Lymphocyte Ratio in Advanced HCC Treatment
Voices
Aug 21, 2025, 14:40
Larissa Nekhlyudov Celebrates Leadership of Emily Smith Tonorezos and Michelle Mollica in Cancer Survivorship
Voices
Aug 21, 2025, 14:32
Hayley Jones: McCabe Centre Supports Daffodil Day with 38,000 Daffodils for Cancer Awareness
Voices
Aug 21, 2025, 14:26
Chrystal Paulos: Exciting Opportunities to Build with the Paulos Lab at Winship Cancer Institute